Parkinson's disease: clinical features and diagnosis

J Jankovic - Journal of neurology, neurosurgery & psychiatry, 2008 - jnnp.bmj.com
Objective: Parkinson's disease (PD) is a progressive neurological disorder characterised by
a large number of motor and non-motor features that can impact on function to a variable …

Parkinson's disease

AE Lang, AM Lozano - New England Journal of Medicine, 1998 - Mass Medical Soc
Pathophysiology The establishment of a model of parkinsonism through the administration
of MPTP to nonhuman primates has provided important insights into new therapeutic …

The diagnosis of Parkinson's disease

E Tolosa, G Wenning, W Poewe - The Lancet Neurology, 2006 - thelancet.com
The correct diagnosis of Parkinson's disease is important for prognostic and therapeutic
reasons and is essential for clinical research. Investigations of the diagnostic accuracy for …

Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia

S Kapur, R Zipursky, C Jones… - American journal of …, 2000 - Am Psychiatric Assoc
OBJECTIVE: Since all antipsychotics block dopamine D2 receptors, the authors investigated
how well D2 receptor occupancy in vivo predicts clinical response, extrapyramidal side …

[HTML][HTML] PET/SPECT molecular imaging in clinical neuroscience: recent advances in the investigation of CNS diseases

FM Lu, Z Yuan - Quantitative imaging in medicine and surgery, 2015 - ncbi.nlm.nih.gov
Molecular imaging is an attractive technology widely used in clinical practice that greatly
enhances our understanding of the pathophysiology and treatment in central nervous …

Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study

A Iranzo, F Valldeoriola, F Lomeña… - The Lancet …, 2011 - thelancet.com
Background Serial dopamine transporter (DAT) imaging in patients with Parkinson's disease
(PD) and other synucleinopathies shows progressive nigrostriatal dopaminergic dysfunction …

Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression

Parkinson Study Group, Parkinson Study Group - Jama, 2002 - jamanetwork.com
ContextPramipexole and levodopa are effective medications to treat motor symptoms of
early Parkinson disease (PD). In vitro and animal studies suggest that pramipexole may …

Looking backward to move forward: early detection of neurodegenerative disorders

ST DeKosky, K Marek - Science, 2003 - science.org
Early detection of neurodegenerative disorders would provide clues to the underlying
pathobiology of these diseases and would enable more effective diagnosis and treatment of …

EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2

J Darcourt, J Booij, K Tatsch, A Varrone… - European journal of …, 2010 - Springer
These guidelines summarize the current views of the European Association of Nuclear
Medicine Neuroimaging Committee (ENC). The aim of the guidelines is to assist nuclear …

[123I] FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.

J Booij, G Tissingh, GJ Boer, JD Speelman… - Journal of Neurology …, 1997 - jnnp.bmj.com
OBJECTIVES: The main neuropathological feature in Parkinson's disease is a severe
degeneration of the dopaminergic neurons in the substantia nigra resulting in a loss of …